Abstract: Fluoropolyether compounds that can be used as a lubricant, such as for magnetic recording media. The compounds have a terminal group that includes a phenol or benzene. The fluoropolyether compounds reduce the head to media distance while keeping comparable reliability in a hard disk drive compared to current industrial widely used fluoropolyether based lubricants.

Abstract: Provided herein is a lubricant comprising a compound of Formula I: wherein R1 and R2 are independent and have the structure selected from —(CF2O)x(CF2CF2O)y(CF2CF2CF2O)z(CF2CF2CF2CF2O)w—, x, y, z and w are selected from an integer from 0 to 30; p, and q are selected from an integer from 0 to 3; A and B are independent and have the structure selected from: —(CH2CH(OH)CH2O)jH, and j is an integer selected from 0 to 3.

Abstract: Provided herein is a lubricant including a compound of Formula I L-(CF2CF2O)n—CF2CH2O—N—OCH2CF2O—(CF2CF2O)m-M??(Formula I) wherein L is selected from the group consisting of M is selected from the group consisting of wherein each instance of R1, R2, and R3 is independently selected from the group consisting of hydroxyl, alkoxyl, carbocycyl, phenyl, heterocycyl, piperonyl, carboxyl, alkylamido, acetamido, carbamoyl, N-alkylcarbamoyl, N,N-dialkylcarbamoyl, 2,3-dihydroxy-1-propoxyl, acryloyl, alkacryloyl, methacryloyl, a sustituent of methyl methacrylate, and a substituent of glycidyl ether; and wherein n?1, m?1, and n and m are the same or different.

Abstract: Provided herein is a lubricant comprising a compound of Formula I: wherein R1 and R2 are independent and have the structure selected from —(CF2O)x(CF2CF2O)y(CF2CF2CF2O)z(CF2CF2CF2CF2O)w—, x, y, z and w are selected from an integer from 0 to 30; p, and q are selected from an integer from 0 to 3; A and B are independent and have the structure selected from: —(CH2CH(OH)CH2O)jH, and j is an integer selected from 0 to 3.

Abstract: Fluoropolyether compounds that can be used as a lubricant, such as for magnetic recording media. The compounds have a terminal group that includes a phenol or benzene. The fluoropolyether compounds reduce the head to media distance while keeping comparable reliability in a hard disk drive compared to current industrial widely used fluoropolyether based lubricants.

Abstract: A stable pharmaceutical composition that includes an active agent selected from 1-deoxynojirimycin, a pharmaceutically acceptable salt thereof, or a derivative thereof, and a buffer, wherein the stable pharmaceutical composition is capable of being parenterally administered to a human without deleterious health effects. Pompe disease is an example of a lysosomal storage disorder. Pompe disease is caused by a deficiency in the enzyme acid alpha-glucosidase (GAA). GAA metabolizes glycogen, a storage form of sugar used for energy, into glucose.

Abstract: A stable pharmaceutical composition that includes an active agent selected from 1-deoxynojirimycin, a pharmaceutically acceptable salt thereof, or a derivative thereof, and a buffer, wherein the stable pharmaceutical composition is capable of being parenterally administered to a human without deleterious health effects. Pompe disease is an example of a lysosomal storage disorder. Pompe disease is caused by a deficiency in the enzyme acid alpha-glucosidase (GAA). GAA metabolizes glycogen, a storage form of sugar used for energy, into glucose.

Abstract: Provided herein is a lubricant including a compound of Formula I L-(CF2CF2O)n—CF2CH2O—N—OCH2CF2O—(CF2CF2O)m-M ??(Formula I) wherein L is selected from the group consisting of M is selected from the group consisting of wherein each instance of R1, R2, and R3 is independently selected from the group consisting of hydroxyl, alkoxyl, carbocycyl, phenyl, heterocycyl, piperonyl, carboxyl, alkylamido, acetamido, carbamoyl, N-alkylcarbamoyl, N,N-dialkylcarbamoyl, 2,3-dihydroxy-l-propoxyl, acryloyl, alkacryloyl, methacryloyl, a sustituent of methyl methacrylate, and a substituent of glycidyl ether; and wherein n?1, m?1, and n and m are the same or different.

Abstract: A stable pharmaceutical composition that includes an active agent selected from 1-deoxynojirimycin, a pharmaceutically acceptable salt thereof, or a derivative thereof, and a buffer, wherein the stable pharmaceutical composition is capable of being parenterally administered to a human without deleterious health effects. Pompe disease is an example of a lysosomal storage disorder. Pompe disease is caused by a deficiency in the enzyme acid alpha-glucosidase (GAA). GAA metabolizes glycogen, a storage form of sugar used for energy, into glucose.

Abstract: Provided herein is a lubricant including a compound of Formula I L-(CF2CF2O)n—CF2CH2O—N—OCH2CF2O—(CF2CF2O)m-M??(Formula I) wherein L is selected from the group consisting of M is selected from the group consisting of wherein each instance of R1, R2, and R3 is independently selected from the group consisting of hydroxyl, alkoxyl, carbocycyl, phenyl, heterocycyl, piperonyl, carboxyl, alkylamido, acetamido, carbamoyl, N-alkylcarbamoyl, N,N-dialkylcarbamoyl, 2,3-dihydroxy-1-propoxyl, acryloyl, alkacryloyl, methacryloyl, a substituent of methyl methacrylate, and a substituent of glycidyl ether; and wherein n?1, m?1, and n and m are the same or different.

Abstract: A stable pharmaceutical composition that includes an active agent selected from 1-deoxynojirimycin, a pharmaceutically acceptable salt thereof, or a derivative thereof, and a buffer, wherein the stable pharmaceutical composition is capable of being parenterally administered to a human without deleterious health effects. Pompe disease is an example of a lysosomal storage disorder. Pompe disease is caused by a deficiency in the enzyme acid alpha-glucosidase (GAA). GAA metabolizes glycogen, a storage form of sugar used for energy, into glucose.

Abstract: A magnetic data storage medium may include a substrate, a magnetic recording layer, a protective carbon overcoat, and a monolayer covalently bound to carbon atoms adjacent a surface of the protective carbon overcoat. According to this aspect of the disclosure, the monolayer comprises at least one of hydrogen, fluorine, nitrogen, oxygen, and a fluoro-organic molecule. In some embodiments, a surface of a read and recording head may also include a monolayer covalently bound to carbon atoms of a protective carbon overcoat.

Abstract: Compositions for use in lubricating thin film storage media are provided, as well as storage media formed using the compositions, the compositions including one or more central cores having a cyclic group, and a plurality of arms extending from the central cores, wherein each arm comprises phenol or piperonyl. Methods of preparing the compositions are also provided. Methods of preparing storage media that incorporate the compositions therein are further provided.

Abstract: A compound of Formula (I) includes: [L]1-[N]n—OCH2CF2O(CF2CF2O)p(CF2O)qCF2CH2O—[M]m, where L is selected from the group consisting of (AA) M is selected from the group consisting of (BB) and N is (CC) where R1, R2, and R3 may be the same or different, and are selected from the group consisting of hydroxyl, phenyl, piperonyl, carboxylic acid, amide, 2,3-di-hydroxy-1-propoxyl, acetamide, methacrylate, methyl methacrylate and glycidyl ether; and where 1=0, 1, or 2, m=0, 1, or 2, n=1 or 2, and the ratio of p to q is from about 0.1 to 3.0.

Abstract: Compositions including one or more a central cores having a cyclic group, and a plurality of arms extending from the central cores, wherein the arms comprise perfluoropolyethers (PFPEs) or its derivatives. Methods of preparing the compositions are also provided. Methods of preparing storage media that incorporate the compositions therein are further provided.

Abstract: A magnetic data storage medium may include a substrate, a magnetic recording layer, a protective carbon overcoat, and a monolayer covalently bound to carbon atoms adjacent a surface of the protective carbon overcoat. According to this aspect of the disclosure, the monolayer comprises at least one of hydrogen, fluorine, nitrogen, oxygen, and a fluoro-organic molecule. In some embodiments, a surface of a read and recording head may also include a monolayer covalently bound to carbon atoms of a protective carbon overcoat.

Abstract: A compound comprising a backbone with a perfluoropolyether chain. The compound also has one or more cyclophosphazene rings attached to or incorporated into the backbone. The compound further includes at least two functional groups attached to the backbone, attached to the one or more cyclophosphazene rings, or a combination thereof.

Abstract: A magnetic data storage medium may include a substrate, a magnetic recording layer, a protective carbon overcoat, and a monolayer covalently bound to carbon atoms adjacent a surface of the protective carbon overcoat. According to this aspect of the disclosure, the monolayer comprises at least one of hydrogen, fluorine, nitrogen, oxygen, and a fluoro-organic molecule. In some embodiments, a surface of a read and recording head may also include a monolayer covalently bound to carbon atoms of a protective carbon overcoat.

Abstract: Compositions including one or more a central cores having a cyclic group, and a plurality of arms extending from the central cores, wherein the arms comprise perfluoropolyethers (PFPEs) or its derivatives. Methods of preparing the compositions are also provided. Methods of preparing storage media that incorporate the compositions therein are further provided.

Abstract: Compositions for use in lubricating thin film storage media are provided, as well as storage media formed using the compositions, the compositions including one or more central cores having a cyclic group, and a plurality of arms extending from the central cores, wherein each arm comprises phenol or piperonyl. Methods of preparing the compositions are also provided. Methods of preparing storage media that incorporate the compositions therein are further provided.